Observed effect of age and body mass index on total and complexed PSA: Analysis from a national screening program

Urology

Volumn 65, Issue 4, 2005, Pages 708-712

  Barqawi, Al Baha ^a   Golden, Brian K ^b   O'Donnell, Colin ^b   Brawer, Michael K ^b   Crawford, E David ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD ANALYSIS; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER SCREENING; CLINICAL OBSERVATION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; REGRESSION ANALYSIS; SCREENING TEST;

EID: 17144385162     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.10.074     Document Type: Article

References (33)

1. G. Bartsch, W. Horninger, H. Klocker Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria Urology 58 2001 417 424
2. P.W. Nicholson, S.J. Harland Survival prospects after screen-detection of prostate cancer BJU Int 90 2002 686 693
3. A. Jemal, R.C. Tiwari, T. Murray Cancer statistics, 2004 CA Cancer J Clin 54 2004 8 29
4. L. Martinez-Pineiro, J.M. Garcia Mediero, P. Gonzalez Gancedo Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4-10 ng/ml World J Urol 22 2004 124 131
5. B.S. Kramer, M.L. Brown, P.C. Prorok Prostate cancer screening what we know and what we need to know Ann Intern Med 119 1993 914 923
6. R. Harris, K.N. Lohr Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 137 2002 917 929
7. H. Lilja Significance of different molecular forms of serum PSA the free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin Urol Clin North Am 20 1993 681 686
8. M.K. Brawer, G.E. Meyer, J.L. Letran Measurement of complexed PSA improves specificity for early detection of prostate cancer Urology 52 1998 372 378
9. B. Martin, C.D. Cheli, D. Lifsey Complexed PSA performance for prostate cancer detection in an African-American population Urology 62 2003 835 839
10. M.C. Miller, G.J. O'Dowd, A.W. Partin Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer impact of changing disease demographics Urology 57 2001 1105 1111
11. R.W. Veltri, M.C. Miller, G.J. O'Dowd Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer Urology 60 4 suppl 1 2002 47 52
12. K.M. Flegal, M.D. Carroll, R.J. Kuczmarski Overweight and obesity in the United States prevalence and trends, 1960-1994 Int J Obes Relat Metab Disord 22 1998 39 47
13. J. Irani, O. Lefebvre, F. Murat Obesity in relation to prostate cancer risk comparison with a population having benign prostatic hyperplasia BJU Int 91 2003 482 484
14. S.J. Freedland, M.K. Terris, J.C. Presti Jr Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins J Urol 172 2004 520 524
15. I.M. Thompson, R. Leach, D. Troyer Relationship of body mass index and prostate specific antigen in a population-based study Urol Oncol 22 2004 127 131
16. J.J. Cartledge, D. Thompson, H. Verril The stability of free and bound prostate-specific antigen BJU Int 84 1999 810 814
17. A.W. Partin, H.B. Carter, D.W. Chan Prostate specific antigen in the staging of localized prostate cancer influence of tumor differentiation, tumor volume and benign hyperplasia J Urol 143 1990 747 752
18. I.M. Thompson, D.K. Pauler, P.J. Goodman Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter N Engl J Med 350 2004 2239 2246
19. U.H. Stenman, M. Hakama, P. Knekt Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer Lancet 357 2001 1201 1202
20. I.D. Mitchell, B.L. Croal, A. Dickie A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer J Urol 165 2001 1549 1553
21. A.W. Partin, M.K. Brawer, G. Bartsch Complexed prostate specific antigen improves specificity for prostate cancer detection results of a prospective multicenter clinical trial J Urol 170 2003 1787 1791
22. W.J. Catalona, C.G. Ramos, G.F. Carvalhal Lowering PSA cutoffs to enhance detection of curable prostate cancer Urology 55 2000 791 795
23. A. Must, J. Spadano, E.H. Coakley The disease burden associated with overweight and obesity JAMA 282 1999 1523 1529
24. J. Irani, O. Lefebvre, F. Murat Obesity in relation to prostate cancer risk comparison with a population having benign prostatic hyperplasia BJU Int 91 2003 482 484
25. E.E. Calle, C. Rodriguez, K. Walker-Thurmond Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
26. C.L. Amling, R.H. Riffenburgh, L. Sun Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy J Clin Oncol 22 2004 439 445
27. C. Rodriguez, A.V. Patel, E.E. Calle Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States Cancer Epidemiol Biomarkers Prev 10 2001 345 353
28. S.O. Andersson, A. Wolk, R. Bergstrom Body size and prostate cancer a 20-year follow-up study among 135,006 Swedish construction workers J Natl Cancer Inst 89 1997 385 389
29. A. Tchernof, J.P. Despres, A. Belanger Reduced testosterone and adrenal C19 steroid levels in obese men Metabolism 44 1995 513 519
30. J.P. Deslypere, L. Verdonck, A. Vermeulen Fat tissue a steroid reservoir and site of steroid metabolism J Clin Endocrinol Metab 61 1985 564 570
31. M.R. Kim, M.K. Gupta, S.H. Travers Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys Clin Endocrinol (Oxf) 50 1999 203 210
32. A. Mifsud, A.T. Choon, D. Fang Prostate-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men Mol Hum Reprod 7 2001 1007 1013
33. S.O. Asbell, K.C. Raimane, A.T. Montesano Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients J Natl Med Assoc 92 2000 445 449